Back to SMMT

Elmind Capital, LP → SMMT

Elmind Capital, LP SMMT Position History

Summit Therapeutics Inc. • Healthcare

Quarters held
2
Latest value
$8.4M
Q3 2026
Peak value
$8.4M
First seen
Q2 2026

Dollar value over time

Show data table
PeriodPosition value
Q2 2026$7.2M
Q3 2026$8.4M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$8.4M493.8K——
Q2 2026$7.2M493.8K——

Other funds holding SMMT

Other Elmind Capital, LP positions

COGT

COGENT BIOSCIENCES INC

$45.3M
COGT

COGENT BIOSCIENCES INC

$45.1M
SNDX

SYNDAX PHARMACEUTICALS INC

$43.3M
COGT

COGENT BIOSCIENCES INC

$41.6M
SNDX

SYNDAX PHARMACEUTICALS INC

$40.6M
SNDX

SYNDAX PHARMACEUTICALS INC

$39M
CLDX

CELLDEX THERAPEUTICS INC NEW

$36.8M
CLDX

CELLDEX THERAPEUTICS INC NEW

$36M